Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 20 of 117 results
Applied Filters
必威体育登录手机In this technical overview, we embedded a single HT-1080 tumor spheroid into extracellular matrix, using the 3D spheroid invasion module of the Agilent xCELLigence RTCA eSight system to continuously acquire brightfield and fluorescent channel images...
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
Using real-time cell potency and bioenergetic assays to optimize critical process parameters for manufacturing of engineered T cells.
Using real-time cell potency and bioenergetic assays to optimize critical process parameters for manufacturing of engineered T cells with eSight and Seahorse technology.
This application note demonstrates the signal recording of the xCELLigence RTCA eSight, enabling visualization and quantification of cell migration and invasion and the speed of wound closure healing.
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
必威体育登录手机The Agilent xCELLigence RTCA DP system expands the throughput and application options xCELLigence Real-Time Cell Analysis (RTCA) portfolio featuring a dual-purpose (DP) format.
必威体育登录手机Integrating the Agilent xCELLigence Real Time Cell Analyzer (RTCA) HT instrument with the Agilent BioTek BioSpa 8 automated incubator expands the screening throughput of your RTCA HT instrument.
Multiparametric real-time automated readouts using simultaneous cellular impedance and live cell imaging.
必威体育登录手机Technical overview describes a method for monoclonal cell isolation using a live cell analysis system, the Agilent xCELLigence RTCA eSight, with a limiting dilution cloning method.
必威体育登录手机The Agilent xCELLigence Real-Time Cell Analysis (RTCA) Software Pro is an integrated software package to generate and analyze data obtained from xCELLigence RTCA DP, SP, MP, S16, and HT instruments.
必威体育登录手机This application note evaluates the Agilent xCELLigence RTCA eSight as a tool to monitor BiTE antibody-mediated cancer cell lysis.
The xCELLigence RTCA S16 system uses biosensors to continuously monitor live cell proliferation, morphological changes, and attachment quality in a label-free and real-time manner.
The eSight platform provides an efficient way to dynamically monitor immune cell activation and clustering to advance tumor immunotherapy development.Here, we evaluate CAR-T and NK92 cell killing efficacy.
必威体育登录手机Agilent xCELLigence Real-Time Cell Analyzer HT-Biotek BioSpa 8 specifications data sheet.
必威体育登录手机Agilent xCELLigence RTCA S16 System Data Sheet.
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
必威体育登录手机This application note demonstrates the feasibility and use of combining multiple cell-based in vitro assays from Agilent that use diverse analytical technologies to investigate the cardiac liability of drugs.
This application note describes pulse labeling methods based on inorganic quantum dots, organic nanoparticles, dyes that covalently modify cytoplasmic proteins, and baculovirus.After evaluating each reagent's labeling efficiency across a population...
This tech note demonstrates the ability of the RTCA eSight assay to identify and characterize antiviral drugs using adenovirus as a model system in real time.